Log in
Enquire now
‌

US Patent 9206252 Pharmaceutical compositions comprising IL-1B binding antibodies and fragments thereof

Patent 9206252 was granted and assigned to XOMA on December, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
XOMA
XOMA
0
Current Assignee
XOMA
XOMA
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
92062520
Date of Patent
December 8, 2015
0
Patent Application Number
137397070
Date Filed
January 11, 2013
0
Patent Citations Received
‌
US Patent 11912761 IL-1β neutralizing human monoclonal antibodies
0
‌
US Patent 11702471 IL-1β neutralizing human monoclonal antibodies
0
‌
US Patent 11780913 IL-1β neutralizing human monoclonal antibodies
Patent Primary Examiner
‌
Prema Mertz
0
Patent abstract

An IL-1β binding antibody or IL-1β binding fragment thereof comprising the amino acid sequence of SEQ ID NO: 2, and related nucleic acids, vectors, cells, and compositions, as well as method of using same to treat or prevent a disease, and a method of preparing an affinity matured IL-1β binding polypeptide. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9206252 Pharmaceutical compositions comprising IL-1B binding antibodies and fragments thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.